Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Speers, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Speers, C. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4467-4468
© 2003 American Society for Clinical Oncology


CORRESPONDENCE

Staging Reclassification Affects Breast Cancer Survival

Ivo A. Olivotto, Pauline T. Truong, Caroline H. Speers

Breast Cancer Outcomes Unit, B.C. Cancer Agency and University of British Columbia, Victoria, British Columbia, Canada

To the Editor: We read with interest the observation of the "Will Rogers" phenomenon described by Woodward et al1 in their institutional series of 1,350 patients with mainly node-positive breast cancer treated with anthracycline chemotherapy at the University of Texas M.D. Anderson Cancer Center. We have examined the effect of changes in the sixth edition of the 2003 American Joint Committee on Cancer (AJCC) staging system,2 in a population-based series of 12,125 patients with newly diagnosed breast cancer referred to one of four BC Cancer Agency Centres in British Columbia, Canada, from 1989 to 1997. Our observations confirm those of Woodward et al and demonstrate applicability to the general population of patients with breast cancer.

The 2003 AJCC staging classification changes dependent on the number of involved nodes had the most dramatic effect. Compared to the AJCC fifth edition classification, nodal stage in the 2003 version separates patients with nodal involvement more reliably into prognostic groups (Fig 1Go). Our data confirm that the staging reclassifications effectively improves survival for N1, N2, and N3 subgroups. The overall effect on survival by stage is less dramatic (Fig 2Go). Our population-based data demonstrate modest improvements to prognosis for patients with stage II and III breast cancer but no noticeable change for women with stage I or IV breast cancer. These observations have important implications for the design and reporting of clinical research and in communicating prognosis to patients.



View larger version (13K):
[in this window]
[in a new window]
 
Fig 1. Ten-year prognosis according to nodal stage according to the American Joint Committee on Cancer tumor-node-metastasis system classification of breast tumors fifth edition (A; 1988) and sixth edition (B; 2003).

 


View larger version (13K):
[in this window]
[in a new window]
 
Fig 2. Ten-year prognosis according to overall stage according to the American Joint Committee on Cancer tumor-node-metastasis system classification of breast tumors fifth edition (A; 1988) and sixth edition (B; 2003).

 
AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

REFERENCES

1. Woodward WA, Strom EA, Tucker SL, et al: Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21:3244–3248, 2003[Abstract/Free Full Text]

2. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636, 2002[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. Querzoli, M. Pedriali, R. Rinaldi, A. R. Lombardi, E. Biganzoli, P. Boracchi, S. Ferretti, C. Frasson, C. Zanella, S. Ghisellini, et al.
Axillary Lymph Node Nanometastases Are Prognostic Factors for Disease-Free Survival and Metastatic Relapse in Breast Cancer Patients.
Clin. Cancer Res., November 15, 2006; 12(22): 6696 - 6701.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Speers, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivotto, I. A.
Right arrow Articles by Speers, C. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online